What is Buck Institute?
The Buck Institute is a globally recognized pioneer dedicated to identifying and impeding the biological processes of aging. By fostering a multidisciplinary environment, the institute brings together elite scientists to address the primary risk factors associated with chronic conditions such as Alzheimer's, Parkinson's, cancer, and heart disease. Its primary objective is to extend the human healthspan, ensuring that individuals not only live longer but maintain a higher quality of life throughout their later years. The institute's research model is characterized by its rigorous scientific approach and its commitment to open-access discovery, which has established it as a cornerstone of modern biomedical research.
How much funding has Buck Institute raised?
Buck Institute has raised a total of $2M across 1 funding round:
Debt
$2M
Debt (2020): $2M with participation from PPP
Key Investors in Buck Institute
PPP
Public-Private Partnership
What's next for Buck Institute?
Looking ahead, the Buck Institute is poised to leverage this capital to deepen its investigation into the molecular pathways of aging. The strategic allocation of these funds will likely focus on scaling laboratory infrastructure and enhancing collaborative research programs that bridge the gap between academic discovery and clinical application. As the global population ages, the demand for innovative solutions to age-related morbidity is reaching an inflection point. The Buck Institute's ability to maintain its trajectory of growth and scientific excellence will be critical in shaping the future of healthcare, potentially unlocking new paradigms for disease prevention and long-term wellness management.
See full Buck Institute company page
